Get the Stockscreener App
713.16
1.78%
-9.78
Idexx Laboratories Inc stock is traded at $713.16, with a volume of 104.21K.
It is down -1.78% in the last 24 hours and up +12.50% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$722.94
Open:
$717.44
24h Volume:
104.21K
Relative Volume:
0.20
Market Cap:
$57.06B
Revenue:
$4.04B
Net Income/Loss:
$985.66M
P/E Ratio:
59.36
EPS:
12.0143
Net Cash Flow:
$774.34M
1W Performance:
+11.94%
1M Performance:
+12.50%
6M Performance:
+50.47%
1Y Performance:
+71.30%
1-Day Range:
$706.59
$726.50
1-Week Range:
$622.08
$735.00
52-Week Range:
$356.14
$735.00
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
713.16 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
TMO
Thermo Fisher Scientific Inc
|
564.15 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.36 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
146.38 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
212.50 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Upgrade | Stifel | Hold → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
IDEXX Laboratories (NASDAQ:IDXX) Releases FY 2025 Earnings Guidance - MarketBeat
Idexx Laboratories (IDXX) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research
IDEXX Laboratories (NASDAQ:IDXX) Posts Quarterly Earnings Results, Beats Estimates By $0.26 EPS - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2025 Earnings Call Transcript - Insider Monkey
Meta Platforms, S&P Global And A Health Care Stock: CNBC's 'Final Trades' - Benzinga
Fund Update: 16,825 IDEXX LABS (IDXX) shares added to KEYBANK NATIONAL ASSOCIATION|OH portfolio - Quiver Quantitative
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $823 From $761, Maintains Outperform Rating - MarketScreener
Rothschild & Co Redburn Adjusts PT on IDEXX Laboratories to $700 From $670, Maintains Neutral Rating - MarketScreener
Why Analysts See the IDEXX Story Shifting With Upgraded Forecasts and Improved Growth Momentum - Yahoo Finance
IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects (NASDAQ:IDXX) - Seeking Alpha
1,171 Shares in IDEXX Laboratories, Inc. $IDXX Bought by Intellectus Partners LLC - MarketBeat
Why retail investors favor IDEXX Laboratories Inc. stockMarket Trend Review & Safe Swing Trade Setup Alerts - newser.com
Does IDEXX Laboratories Inc. fit your quant trading modelDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com
Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
Idexx Laboratories stock reaches 52-week high at $693.00 By Investing.com - Investing.com India
IDEXX Laboratories Reports Strong Q3 2025 Results - TipRanks
IDEXX Laboratories Stock Price, Quotes and Forecasts | NASDAQ:IDXX - Benzinga
IDEXX Laboratories Inc. (IDXX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
IDEXX Laboratories Jumps 15% on Q3 Earnings Beat - AOL.com
IDEXX Laboratories (IDXX) Reports Strong Q3 2025 Financial Perfo - GuruFocus
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $785 - 富途牛牛
Daily Market Wrap: Top Stocks – Amazon, Cipher, and Idexx Laboratories - TheStreet
Why Idexx Laboratories Stock Surged by Almost 15% Today - AOL.com
Why Idexx Laboratories Stock Surged by Almost 15% Today - The Motley Fool
IDEXX Stock on the Rise: What’s Driving the Surge? - timothysykes.com
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories Inc (IDXX) Q3 2025 Earnings Call Highlights: - GuruFocus
IDXX Stock Surges: What this Means - StocksToTrade
IDEXX Laboratories Inc (IDXX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
IDEXX Laboratories stock price target raised to $775 by Stifel on growth outlook - Investing.com Nigeria
Earnings call transcript: IDEXX Labs Q3 2025 beats expectations, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: IDEXX Labs Q3 2025 beats expectations, stock surges - Investing.com Canada
Is IDEXX Stock A Smart Buy Now? - timothysykes.com
Stock Markets Diverged As Amazon And IDEXX Stood Out - Finimize
Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday - Benzinga
Micron, IDEXX among market cap stock movers on Monday - Investing.com
IDEXX Laboratories’ Stock Soars: Growth or Bubble? - StocksToTrade
Leerink Partners IDEXX Laboratories' Price Target to $785 From $745 - MarketScreener
Triglav Investments D.O.O. Purchases 725 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Pet Spending Lifts IDEXX Laboratories To Higher Forecasts - Finimize
Research Alert: CFRA Keeps Buy Rating On Shares Of Idexx Laboratories, Inc. - 富途牛牛
Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook - Benzinga
Idexx: Q3 Earnings Snapshot - Stamford Advocate
Transcript : IDEXX Laboratories, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
IDEXX Laboratories Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Idexx Laboratories stock reaches 52-week high at $693.00 - Investing.com
IDEXX (IDXX) Q3 2025 Earnings Call Transcript - The Motley Fool
IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀 - ts2.tech
Earnings Summary: Highlights of IDEXX’s Q3 2025 report - AlphaStreet
IDEXX Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
IDEXX Laboratories (IDXX) Surges as Q3 Results Beat Expectations - GuruFocus
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.48%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):